Next Article in Journal
The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers
Next Article in Special Issue
Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
Previous Article in Journal
Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
Previous Article in Special Issue
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
 
 
Review

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review

1
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany
2
Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany
3
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
4
German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(8), 246; https://doi.org/10.3390/cancers10080246
Received: 6 July 2018 / Revised: 23 July 2018 / Accepted: 25 July 2018 / Published: 27 July 2018
(This article belongs to the Special Issue Cancer Biomarkers)
Background: Several approaches have been suggested to be useful in the early detection of colorectal neoplasms. Since metabolites are closely related to the phenotype and are available from different human bio-fluids, metabolomics are candidates for non-invasive early detection of colorectal neoplasms. Objectives: We aimed to summarize current knowledge on performance characteristics of metabolomics biomarkers that are potentially applicable in a screening setting for the early detection of colorectal neoplasms. Design: We conducted a systematic literature search in PubMed and Web of Science and searched for biomarkers for the early detection of colorectal neoplasms in easy-to-collect human bio-fluids. Information on study design and performance characteristics for diagnostic accuracy was extracted. Results: Finally, we included 41 studies in our analysis investigating biomarkers in different bio-fluids (blood, urine, and feces). Although single metabolites mostly had limited ability to distinguish people with and without colorectal neoplasms, promising results were reported for metabolite panels, especially amino acid panels in blood samples, as well as nucleosides in urine samples in several studies. However, validation of the results is limited. Conclusions: Panels of metabolites consisting of amino acids in blood and nucleosides in urinary samples might be useful biomarkers for early detection of advanced colorectal neoplasms. However, to make metabolomic biomarkers clinically applicable, future research in larger studies and external validation of the results is required. View Full-Text
Keywords: metabolomics; biomarkers; early detection; colorectal neoplasms; sensitivity; specificity; human bio-fluids metabolomics; biomarkers; early detection; colorectal neoplasms; sensitivity; specificity; human bio-fluids
Show Figures

Figure 1

MDPI and ACS Style

Erben, V.; Bhardwaj, M.; Schrotz-King, P.; Brenner, H. Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review. Cancers 2018, 10, 246. https://doi.org/10.3390/cancers10080246

AMA Style

Erben V, Bhardwaj M, Schrotz-King P, Brenner H. Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review. Cancers. 2018; 10(8):246. https://doi.org/10.3390/cancers10080246

Chicago/Turabian Style

Erben, Vanessa, Megha Bhardwaj, Petra Schrotz-King, and Hermann Brenner. 2018. "Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review" Cancers 10, no. 8: 246. https://doi.org/10.3390/cancers10080246

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop